Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$21.6 - $27.79 $270,000 - $347,375
-12,500 Closed
0 $0
Q1 2021

May 04, 2021

SELL
$21.37 - $34.38 $59,429 - $95,610
-2,781 Reduced 18.2%
12,500 $397,000
Q4 2020

Feb 08, 2021

SELL
$15.31 - $21.12 $382 - $528
-25 Reduced 0.16%
15,281 $318,000
Q2 2020

Aug 04, 2020

SELL
$13.31 - $20.51 $29,947 - $46,147
-2,250 Reduced 12.82%
15,306 $280,000
Q1 2020

Apr 29, 2020

SELL
$12.98 - $30.25 $2,271 - $5,293
-175 Reduced 0.99%
17,556 $272,000
Q4 2019

Jan 31, 2020

BUY
$18.89 - $31.89 $15,225 - $25,703
806 Added 4.76%
17,731 $531,000
Q3 2019

Oct 30, 2019

SELL
$20.88 - $25.66 $10,440 - $12,830
-500 Reduced 2.87%
16,925 $370,000
Q2 2019

Aug 05, 2019

SELL
$20.52 - $26.45 $37,449 - $48,271
-1,825 Reduced 9.48%
17,425 $439,000
Q1 2019

May 07, 2019

BUY
$20.23 - $26.29 $20,735 - $26,947
1,025 Added 5.62%
19,250 $475,000
Q4 2018

Feb 01, 2019

BUY
$17.64 - $28.32 $62,622 - $100,536
3,550 Added 24.19%
18,225 $337,000
Q3 2018

Oct 31, 2018

BUY
$20.64 - $25.67 $302,892 - $376,707
14,675 New
14,675 $377,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.7B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Greatmark Investment Partners, Inc. Portfolio

Follow Greatmark Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.